Abstract:Background: Chlamydia trachomatis (chlamydia) is one of the most common sexually transmitted infections (STI) globally, and re-infections are common. Current Australian guidelines recommend re-testing for chlamydia 3 months after treatment to identify possible re-infection. Patient-delivered partner therapy (PDPT) has been proposed to control chlamydia re-infection among heterosexuals. We aimed to identify determinants and the prediction of chlamydia re-testing and re-infection within 1 year among heterosexuals with chlamydia to identify potential PDPT candidates. Methods: Our baseline data included 5,806 heterosexuals with chlamydia aged ≥18 years and 2,070 re-tested for chlamydia within 1 year of their chlamydia diagnosis at the Melbourne Sexual Health Center from January 2, 2015, to May 15, 2020. We used routinely collected electronic health record (EHR) variables and machine-learning models to predict chlamydia re-testing and re-infection events. We also used logistic regression to investigate factors associated with chlamydia re-testing and re-infection. Results: About 2,070 (36%) of 5,806 heterosexuals with chlamydia were re-tested for chlamydia within 1 year. Among those retested, 307 (15%) were re-infected. Multivariable logistic regression analysis showed that older age (≥35 years old), female, living with HIV, being a current sex worker, patient-delivered partner therapy users, and higher numbers of sex partners were associated with an increased chlamydia re-testing within 1 year. Multivariable logistic regression analysis also showed that younger age (18–24 years), male gender, and living with HIV were associated with an increased chlamydia re-infection within 1 year. The XGBoost model was the best model for predicting chlamydia re-testing and re-infection within 1 year among heterosexuals with chlamydia; however, machine learning approaches and these self-reported answers from clients did not provide a good predictive value (AUC < 60.0%). Conclusion: The low rate of chlamydia re-testing and high rate of chlamydia re-infection among heterosexuals with chlamydia highlights the need for further interventions. Better targeting of individuals more likely to be re-infected is needed to optimize the provision of PDPT and encourage the test of re-infection at 3 months.

A group testing based exploration of age-varying factors in chlamydia infections among Iowa residents

Regression analysis of group-tested current status data

Using an agent-based sexual-network model to analyze the impact of mitigation efforts for controlling chlamydia

Modelling the Impact of Screening Men for Chlamydia Trachomatis on the Prevalence in Women

Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities

Spatial Autocorrelation among Automated Geocoding Errors and Its Effects on Testing for Disease Clustering

Using an agent-based sexual-network model to guide mitigation efforts for controlling chlamydia

Mathematical Models for Predicting and Mitigating the Spread of Chlamydia Sexually Transmitted Infection

Generalized Linear Mixed Model Analysis of Urban-Rural Differences in Social and Behavioral Factors for Colorectal Cancer Screening

Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022

HIV Testing Uptake and Yield among Sexual Partners of HIV-positive Men Who Have Sex with Men in Zhejiang Province, China, 2014-2016: A Cross-Sectional Pilot Study of a Choice-Based Partner Tracing and Testing Package

Spatial Clustering of the Failure to Geocode and Its Implications for the Detection of Disease Clustering

Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic

Adaptive Group Testing with Mismatched Models

Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis

Spontaneous Clearance of Chlamydia trachomatis and Its Associated Factors among Women Attending Screening for Chlamydia in Shenzhen, China.

Bayesian group testing regression models for spatial data

Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data

Critical lessons from a pragmatic randomized trial of home‐based COVID‐19 testing in rural Native American and Latino communities

A Likelihood Approach to Incorporating Self-Report Data in HIV Recency Classification